scispace - formally typeset
D

Dada Patil

Researcher at Serum Institute of India (India)

Publications -  19
Citations -  431

Dada Patil is an academic researcher from Serum Institute of India (India). The author has contributed to research in topics: Withania somnifera & High-performance liquid chromatography. The author has an hindex of 10, co-authored 18 publications receiving 367 citations. Previous affiliations of Dada Patil include Savitribai Phule Pune University & Symbiosis International University.

Papers
More filters
Journal ArticleDOI

Immunomodulatory activity of Asparagus racemosus on systemic Th1/Th2 immunity: Implications for immunoadjuvant potential

TL;DR: Mixed Th1/Th2 activity of ARE supports its immunoadjuvant potential, and treatment with ARE resulted in significant increase of CD3(+) and CD4/CD8(+) percentages suggesting its effect on T cell activation.
Journal ArticleDOI

Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral administration of Withania somnifera aqueous extract.

TL;DR: A new, selective and rapid high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method has been developed and validated for simultaneous determination of WA and WLD in mice plasma and revealed that withaferin A has one and half times more relative bioavailability as compared to withanolide A.
Journal ArticleDOI

Development and biological evaluation of Gymnema sylvestre extract-loaded nonionic surfactant-based niosomes

TL;DR: The niosome formulation demonstrated significant blood glucose level reduction in an oral glucose tolerance test, and increased antihyperglycemic activity compared with the parent extract in an alloxan-induced diabetic model, justifying the potential of niosomes for improving the efficacy of G. sylvestre extract as antidiabetic.
Journal ArticleDOI

Physicochemical Stability and Biological Activity of Withania somnifera Extract under Real-Time and Accelerated Storage Conditions

TL;DR: The results suggest a significant decline in withaferin A and withanolide A content under real and accelerated conditions and may help in proposing suitable guidance for storage conditions and shelf life of ashwagandha formulations.
Journal ArticleDOI

Effect of botanical immunomodulators on human CYP3A4 inhibition: implications for concurrent use as adjuvants in cancer therapy

TL;DR: The findings suggest that constituents of TCE extract especially protoberberine alkaloids have the potential to interact with cancer chemotherapy agents that are metabolized by CYP3A4 in vivo.